Guidant Galileo Expanded Intravascular Radiation Indications Slated For 2002
This article was originally published in The Gray Sheet
Executive Summary
Guidant plans to pursue FDA approval of expanded indications for its Galileo beta-emitting intravascular radiation system to treat small vessels and long lesions by the second half of 2002